幹細胞療法市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPHE100000991
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 206
Buy Now

幹細胞療法市場は、2022 年の 22 億 7,849 万米ドルから 2028 年までに 62 億 689 万米ドルに成長すると予想されています。 2022 年から 2028 年にかけて 18.2% の CAGR で成長すると推定されています。

幹細胞は、特殊な機能を持つ他のすべての細胞が生成される予備的な体細胞です。体内または臨床検査室の制御された環境下では、これらの細胞は分裂して、娘細胞と呼ばれるさらに多くの細胞を形成します。現代の健康科学の出現により、これらの細胞は、病気の発生の理解、高度な再生医療の生成、および他の薬剤の発見において重要な役割を果たしていることが証明されています。幹細胞は、胚、骨髄、体脂肪、臍帯血などで形成されます。

戦略的洞察

市場洞察

有機および無機の増加主要企業による戦略

市場の主要企業は、市場での競争力を維持するために、合併と買収、拡張、新製品の発売など、さまざまな有機的および無機的な戦略を講じています。

  • 2022 年 10 月、Medipost (CEO Won-Il Oh) は、韓国での細胞および遺伝子治療製品の受託開発製造組織 (CDMO) ビジネスの立ち上げを発表しました。同社は、新しい GMP 施設に 10 のクリーンルームと、CDMO 専用の最新機器を備えた生産施設を収容すると発表しました。
  • 2019 年 12 月、Lineage Cell Therapeutics と AgeX Therapeutics は提携して、米国特許登録を行いました。
  • 2021 年 6 月、Allogene Therapeutics, Inc. は、米国食品医薬品局 (FDA) が同社の ALLO-605 にファスト トラック指定を付与したと発表しました。 ; 再発性または難治性多発性骨髄腫の治療のための BCMA を標的とした次世代 AlloCAR T 療法。 FDA は、他の標準的な多発性骨髄腫治療法で効果がなかった患者の満たされていないニーズに対処するための ALLO-605 の可能性に基づいて、ファスト トラックの指定を許可しました。

したがって、米国では多くの有機的および無機的戦略が行われています。幹細胞治療市場により、医療専門家は改善されたサービスを提供できるようになります。

幹細胞治療市場の収益性の高い地域

幹細胞治療は、世界中で広く調査されています。幹細胞は主に、死にかけている細胞を置き換え、損傷した組織を再構築するために使用されます。これまでに実施された広範な幹細胞研究の結果に基づいて、多くの科学者は、これらの細胞をおそらく癌や心血管疾患などの病気の治療法や治療法を生み出すために利用できる可能性があると主張してきました。新しく開発された幹細胞療法には、病気の原因となる細胞を幹細胞に置き換えることが含まれます。幹細胞を利用した多くの潜在的な治療法は、臨床試験のさまざまな段階にあります。 FDAはまた、幹細胞移植に関連する合併症の治療に関与するいくつかの幹細胞療法を承認しました。 2021年9月、米国食品医薬品局(FDA)は、12歳以上の患者の「移植片対宿主病」(GVHD)の治療薬として「ルキソリチニブ」の承認を発表した。ルキソリチニブは、幹細胞移植に伴う致命的な合併症に苦しむ患者に新たな希望をもたらします。

研究者らは、自己免疫疾患の治療における幹細胞療法の使用についてさらに研究を進めています。たとえば、幹細胞は損傷を受けた臓器の細胞に変化し、自己免疫疾患の治療に使用されます。治療は間葉系幹細胞や胎児幹細胞を用いて行われます。造血幹細胞は現在、免疫系疾患を含む 80 以上の病状の治療に使用されています。血液疾患;神経学的障害;代謝障害;遺伝性疾患;

タイプに関する洞察

タイプに基づいて、幹細胞療法市場は成人幹細胞療法、人工多能性幹細胞療法、胚性幹細胞療法に分類されます。細胞療法、およびその他の幹細胞療法。成人幹細胞治療セグメントは、2021 年に最大の市場シェアを保持しました。しかし、人工多能性幹細胞治療セグメントは、予測期間 (2022 ~ 2028 年) 中に最高の CAGR を記録すると予想されます。

治療に関する洞察< /h3>

世界の幹細胞治療市場は、治療法に基づいて同種異系と自家に二分されます。同種セグメントは、2021 年の幹細胞療法市場でより大きなシェアを保持しました。さらに、自家セグメントは、予測期間中に最高の CAGR で成長すると予想されます。

Application Insights

用語幹細胞療法の市場は、筋骨格系、皮膚科、心臓病、創薬および開発、その他の用途に分けられます。創薬および開発セグメントは、2021 年に最大の市場シェアを保持しており、予測期間中に最高の CAGR を記録すると予想されます。

種類別の幹細胞療法市場 – 2021 年と 2028 年

エンドユーザーに関する洞察

エンドユーザーに基づいて、幹細胞療法市場は学術市場と学術市場に二分化されます。 &研究機関や病院、クリニック。アカデミック&研究機関セグメントは 2021 年に大きな市場シェアを保持しており、同じセグメントは予測期間 (2022 ~ 2028 年) 中に市場でより高い CAGR を記録すると予想されます。

幹細胞療法市場の企業M&A などの無機戦略が主です。市場における最近の主要な動向のいくつかを以下に示します。

  • 2021 年 6 月、USFDA は次世代 ALLO-605 にファスト トラック指定を付与しました。 Allogene Therapeutics, Inc. が提供する AlloCAR T 療法は、再発または難治性の多発性骨髄腫の治療のために BCMA を標的としています。この指定は、他の標準的な多発性骨髄腫治療法に反応しなかった患者の満たされていないニーズに ALLO-605 が対処できる可能性に基づいて付与されました。
  • 2021 年 6 月、MEDIPOST は次のことを発表しました。同社は、変形性膝関節症幹細胞製品である CARTISTEM と SMUP-IA-01 の生産施設を拡張し、GMP(適正製造基準)認証の準備を開始する予定です。
  • 2022 年 9 月に、Caladrius Biosciences は、Inc.とCend Therapeutics, Inc.は、カラドリウス社の承認を受けて両社の合併計画が完了したと発表した。合併後の会社は Lisata Therapeutics, Inc. として運営され、Caladrius に加えて、さまざまな腫瘍疾患適応症における CendR プラットフォーム技術製品候補の開発に主に焦点を当てます。
  • 2019 年 3 月、BioTime, Inc は再生医療を扱う Asterias Biotherapeutics, Inc. を買収し、幹細胞治療製品ポートフォリオを強化しました。

会社概要

  • メディポスト
  • ファーミセル株式会社
  • リッチソース
  • バイオタイム株式会社
  • Mesoblast Limited
  • Holostem Terapie Avanzate Srl
  • US Stem Cell, Inc.
  • Caladrius Biosciences, Inc.
  • TiGenix NV
  • アロソース
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the stem cell therapy market?

Stem cells are preliminary body cells from which all other cells with specialized functions are generated. Under controlled environment in the body or a clinical laboratory, these cells divide to form more cells called daughter cells. Due to the advent of modern health science, these cells play a major role in understanding the occurrence of diseases, generation of advanced regenerative medicines, and drug discovery. There are certain sources such as embryo, bone marrow, body fats, and umbilical cord blood amongst others, where stem cells are generated.

What are the driving factors for the stem cell therapy market across the globe?

Increasing research activities related to stem cell therapy for effective disease management and growing prevalence of cancer are the most significant factors responsible for the overall market growth.

Which type segment led the stem cell therapy market?

Based on type segment, the adult stem cell therapy segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which treatment segment held the largest market share in the stem cell therapy market?

Based on the treatment, allogenic segment took the forefront leaders in the worldwide market by accounting largest share in 2021.

Which end user segment held the largest market share in the stem cell therapy market?

Academic & Research institutes segment dominated the global stem cell therapy market and accounted for the largest market share during the forecast period of 2022-2028.

Who are the key players in the stem cell therapy market?

MEDIPOST, RichSource, BioTime, Inc., Mesoblast Limited, Holostem Terapie Avanzate Srl, U.S. Stem Cell, Inc., TiGenix NV, AlloSource, NuVasive Inc, JCR Pharmaceuticals Co. Ltd. and among others are among the leading companies operating in the stem cell therapy market.

What is the regional market scenario of the stem cell therapy market?

Global stem cell therapy market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.

The List of Companies - Stem Cell Therapy Market

  1. MEDIPOST
  2. RichSource
  3. BioTime, Inc.
  4. Mesoblast Limited
  5. Holostem Terapie Avanzate Srl
  6. U.S. Stem Cell, Inc.
  7. TiGenix NV
  8. AlloSource
  9. NuVasive Inc
  10. JCR Pharmaceuticals Co. Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports